Enlivex Therapeutics (NASDAQ:ENLV) Stock Rating Lowered by Wall Street Zen

Enlivex Therapeutics (NASDAQ:ENLV) Stock Rating Lowered by Wall Street Zen

Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other analysts have also commented on ENLV. HC Wainwright lifted their target price on Enlivex Therapeutics from $7.00 to $13.00 and gave the stock a “buy” rating in a report on Monday, January 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of …